OBJECTIVE: To explore the association between APOE*4 and pathologically confirmed cases of the Lewy body (LB) variant of Alzheimer disease (AD). METHODS: With use of alpha-synuclein (AS) immunohistochemistry, LBs were detected in 74 of 131 (56.5%) of the AD + LB cases; the remaining 57 cases (43.5%) did not have LBs. RESULTS: There were no differences in gender or age between Caucasian subjects with AD + LB or AD alone or control subjects. The APOE*4 allele frequency was highest in the AD + LB group (47.3%; 95% CI = 37.8 to 57.0%), intermediate in the AD-alone group (35.1%; 95% CI = 25.3 to 46.3%), and lowest in the control group (14.2%; 95% CI = 10.5 to 18.9%). With use of logistic regression analysis, the odds of having AD + LB vs AD alone were 2.1-fold (95% CI = 1.0 to 4.5, p = 0.055) greater in persons with an APOE*4 allele than in those without an APOE*4 allele. CONCLUSION: The APOE*4 allele is associated with the presence of concomitant Lewy bodies in Alzheimer disease.
OBJECTIVE: To explore the association between APOE*4 and pathologically confirmed cases of the Lewy body (LB) variant of Alzheimer disease (AD). METHODS: With use of alpha-synuclein (AS) immunohistochemistry, LBs were detected in 74 of 131 (56.5%) of the AD + LB cases; the remaining 57 cases (43.5%) did not have LBs. RESULTS: There were no differences in gender or age between Caucasian subjects with AD + LB or AD alone or control subjects. The APOE*4 allele frequency was highest in the AD + LB group (47.3%; 95% CI = 37.8 to 57.0%), intermediate in the AD-alone group (35.1%; 95% CI = 25.3 to 46.3%), and lowest in the control group (14.2%; 95% CI = 10.5 to 18.9%). With use of logistic regression analysis, the odds of having AD + LB vs AD alone were 2.1-fold (95% CI = 1.0 to 4.5, p = 0.055) greater in persons with an APOE*4 allele than in those without an APOE*4 allele. CONCLUSION: The APOE*4 allele is associated with the presence of concomitant Lewy bodies in Alzheimer disease.
Authors: Christopher M Lauderback; Jaroslaw Kanski; Janna M Hackett; Noboyo Maeda; Mark S Kindy; D Allan Butterfield Journal: Brain Res Date: 2002-01-04 Impact factor: 3.252
Authors: E Masliah; E Rockenstein; I Veinbergs; Y Sagara; M Mallory; M Hashimoto; L Mucke Journal: Proc Natl Acad Sci U S A Date: 2001-09-25 Impact factor: 11.205
Authors: A Heyman; G G Fillenbaum; M Gearing; S S Mirra; K A Welsh-Bohmer; B Peterson; C Pieper Journal: Neurology Date: 1999-06-10 Impact factor: 9.910
Authors: Y J Li; M A Hauser; W K Scott; E R Martin; M W Booze; X J Qin; J W Walter; M A Nance; J P Hubble; W C Koller; R Pahwa; M B Stern; B C Hiner; J Jankovic; C G Goetz; G W Small; F Mastaglia; J L Haines; M A Pericak-Vance; J M Vance Journal: Neurology Date: 2004-06-08 Impact factor: 9.910
Authors: Megan Zuelsdorff; Ozioma C Okonkwo; Derek Norton; Lisa L Barnes; Karen L Graham; Lindsay R Clark; Mary F Wyman; Susan F Benton; Alexander Gee; Nickolas Lambrou; Sterling C Johnson; Carey E Gleason Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Jennifer L Whitwell; David S Knopman; Mary M Machulda; Stephen D Weigand; Bradley F Boeve; Kejal Kantarci; Leonard Petrucelli; Val J Lowe; Clifford R Jack; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson Journal: Acta Neuropathol Date: 2017-02-03 Impact factor: 17.088
Authors: Willa D Brenowitz; C Dirk Keene; Stephen E Hawes; Rebecca A Hubbard; W T Longstreth; Randy L Woltjer; Paul K Crane; Eric B Larson; Walter A Kukull Journal: Neurobiol Aging Date: 2017-01-30 Impact factor: 4.673
Authors: Jessica Tulloch; Lesley Leong; Sunny Chen; C Dirk Keene; Steven P Millard; Andrew Shutes-David; Oscar L Lopez; Julia Kofler; Jeffrey A Kaye; Randy Woltjer; Peter T Nelson; Janna H Neltner; Gregory A Jicha; Douglas Galasko; Eliezer Masliah; James B Leverenz; Chang-En Yu; Debby Tsuang Journal: Alzheimers Dement Date: 2018-03-12 Impact factor: 21.566
Authors: Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian Journal: JAMA Neurol Date: 2013-02 Impact factor: 18.302
Authors: Gregory A Jicha; Joseph E Parisi; Dennis W Dickson; Ruth H Cha; Kris A Johnson; Glenn E Smith; Bradley F Boeve; Ronald C Petersen; David S Knopman Journal: J Neurol Sci Date: 2008-07-23 Impact factor: 3.181